A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism
Primary aldosteronism is the most common and curable form of secondary arterial hypertension. We performed whole-exome sequencing in patients with early-onset primary aldosteronism and identified a de novo heterozygous c.71G>A/p.Gly24Asp mutation in the CLCN2 gene, encoding the voltage-gated ClC-...
Saved in:
Published in | Nature genetics Vol. 50; no. 3; pp. 355 - 361 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.03.2018
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 1061-4036 1546-1718 1546-1718 |
DOI | 10.1038/s41588-018-0053-8 |
Cover
Abstract | Primary aldosteronism is the most common and curable form of secondary arterial hypertension. We performed whole-exome sequencing in patients with early-onset primary aldosteronism and identified a de novo heterozygous c.71G>A/p.Gly24Asp mutation in the
CLCN2
gene, encoding the voltage-gated ClC-2 chloride channel
1
, in a patient diagnosed at 9 years of age. Patch-clamp analysis of glomerulosa cells of mouse adrenal gland slices showed hyperpolarization-activated Cl
–
currents that were abolished in
Clcn2
−/−
mice. The p.Gly24Asp variant, located in a well-conserved ‘inactivation domain’
2
,
3
, abolished the voltage- and time-dependent gating of ClC-2 and strongly increased Cl
–
conductance at resting potentials. Expression of ClC-2
Asp24
in adrenocortical cells increased expression of aldosterone synthase and aldosterone production. Our data indicate that
CLCN2
mutations cause primary aldosteronism. They highlight the important role of chloride in aldosterone biosynthesis and identify ClC-2 as the foremost chloride conductor of resting glomerulosa cells.
A gain-of-function mutation in the
CLCN2
chloride channel gene (encoding ClC-2) causes primary aldosteronism. The mutation abolishes voltage-dependent gating of ClC-2, highlighting a role for chloride conduction in regulating aldosterone biosynthesis. |
---|---|
AbstractList | Primary aldosteronism is the most common and curable form of secondary arterial hypertension. We performed whole-exome sequencing in patients with early-onset primary aldosteronism and identified a de novo heterozygous c.71G>A/p.Gly24Asp mutation in the CLCN2 gene, encoding the voltage-gated ClC-2 chloride channel 1 , in a patient diagnosed at 9 years of age. Patch-clamp analysis of glomerulosa cells of mouse adrenal gland slices showed hyperpolarization-activated Cl- currents that were abolished in Clcn2-/- mice. The p.Gly24Asp variant, located in a well-conserved 'inactivation domain'2,3, abolished the voltage- and time-dependent gating of ClC-2 and strongly increased Cl- conductance at resting potentials. Expression of ClC-2Asp24 in adrenocortical cells increased expression of aldosterone synthase and aldosterone production. Our data indicate that CLCN2 mutations cause primary aldosteronism. They highlight the important role of chloride in aldosterone biosynthesis and identify ClC-2 as the foremost chloride conductor of resting glomerulosa cells. Primary aldosteronism is the most common and curable form of secondary arterial hypertension. We performed whole-exome sequencing in patients with early-onset primary aldosteronism and identified a de novo heterozygous c.71G>A/p.Gly24Asp mutation in the CLCN2 gene, encoding the voltage-gated ClC-2 chloride channel 1 , in a patient diagnosed at 9 years of age. Patch-clamp analysis of glomerulosa cells of mouse adrenal gland slices showed hyperpolarization-activated Cl – currents that were abolished in Clcn2 −/− mice. The p.Gly24Asp variant, located in a well-conserved ‘inactivation domain’ 2 , 3 , abolished the voltage- and time-dependent gating of ClC-2 and strongly increased Cl – conductance at resting potentials. Expression of ClC-2 Asp24 in adrenocortical cells increased expression of aldosterone synthase and aldosterone production. Our data indicate that CLCN2 mutations cause primary aldosteronism. They highlight the important role of chloride in aldosterone biosynthesis and identify ClC-2 as the foremost chloride conductor of resting glomerulosa cells. A gain-of-function mutation in the CLCN2 chloride channel gene (encoding ClC-2) causes primary aldosteronism. The mutation abolishes voltage-dependent gating of ClC-2, highlighting a role for chloride conduction in regulating aldosterone biosynthesis. Primary aldosteronism is the most common and curable form of secondary arterial hypertension. We performed whole-exome sequencing in patients with early-onset primary aldosteronism and identified a de novo heterozygous c.71G>A/p.Gly24Asp mutation in the CLCN2 gene, encoding the voltage-gated ClC-2 chloride channel 1 , in a patient diagnosed at 9 years of age. Patch-clamp analysis of glomerulosa cells of mouse adrenal gland slices showed hyperpolarization-activated Cl- currents that were abolished in Clcn2-/- mice. The p.Gly24Asp variant, located in a well-conserved 'inactivation domain'2,3, abolished the voltage- and time-dependent gating of ClC-2 and strongly increased Cl- conductance at resting potentials. Expression of ClC-2Asp24 in adrenocortical cells increased expression of aldosterone synthase and aldosterone production. Our data indicate that CLCN2 mutations cause primary aldosteronism. They highlight the important role of chloride in aldosterone biosynthesis and identify ClC-2 as the foremost chloride conductor of resting glomerulosa cells.Primary aldosteronism is the most common and curable form of secondary arterial hypertension. We performed whole-exome sequencing in patients with early-onset primary aldosteronism and identified a de novo heterozygous c.71G>A/p.Gly24Asp mutation in the CLCN2 gene, encoding the voltage-gated ClC-2 chloride channel 1 , in a patient diagnosed at 9 years of age. Patch-clamp analysis of glomerulosa cells of mouse adrenal gland slices showed hyperpolarization-activated Cl- currents that were abolished in Clcn2-/- mice. The p.Gly24Asp variant, located in a well-conserved 'inactivation domain'2,3, abolished the voltage- and time-dependent gating of ClC-2 and strongly increased Cl- conductance at resting potentials. Expression of ClC-2Asp24 in adrenocortical cells increased expression of aldosterone synthase and aldosterone production. Our data indicate that CLCN2 mutations cause primary aldosteronism. They highlight the important role of chloride in aldosterone biosynthesis and identify ClC-2 as the foremost chloride conductor of resting glomerulosa cells. Primary aldosteronism is the most common and curable form of secondary arterial hypertension. We performed whole-exome sequencing in patients with early-onset primary aldosteronism and identified a de novo heterozygous c.71G>A/p.Gly24Asp mutation in the CLCN2 gene, encoding the voltage-gated ClC-2 chloride channel.sup.1, in a patient diagnosed at 9 years of age. Patch-clamp analysis of glomerulosa cells of mouse adrenal gland slices showed hyperpolarization-activated Cl.sup.- currents that were abolished in Clcn2.sup.-/- mice. The p.Gly24Asp variant, located in a well-conserved 'inactivation domain'.sup.2,3, abolished the voltage- and time-dependent gating of ClC-2 and strongly increased Cl.sup.- conductance at resting potentials. Expression of ClC-2.sup.Asp24 in adrenocortical cells increased expression of aldosterone synthase and aldosterone production. Our data indicate that CLCN2 mutations cause primary aldosteronism. They highlight the important role of chloride in aldosterone biosynthesis and identify ClC-2 as the foremost chloride conductor of resting glomerulosa cells. A gain-of-function mutation in the CLCN2 chloride channel gene (encoding ClC-2) causes primary aldosteronism. The mutation abolishes voltage-dependent gating of ClC-2, highlighting a role for chloride conduction in regulating aldosterone biosynthesis. Primary aldosteronism is the most common and curable form of secondary arterial hypertension. We performed whole-exome sequencing in patients with early-onset primary aldosteronism and identified a de novo heterozygous c.71G>A/p.Gly24Asp mutation in the CLCN2 gene, encoding the voltage-gated ClC-2 chloride channel.sup.1, in a patient diagnosed at 9 years of age. Patch-clamp analysis of glomerulosa cells of mouse adrenal gland slices showed hyperpolarization-activated Cl.sup.- currents that were abolished in Clcn2.sup.-/- mice. The p.Gly24Asp variant, located in a well-conserved 'inactivation domain'.sup.2,3, abolished the voltage- and time-dependent gating of ClC-2 and strongly increased Cl.sup.- conductance at resting potentials. Expression of ClC-2.sup.Asp24 in adrenocortical cells increased expression of aldosterone synthase and aldosterone production. Our data indicate that CLCN2 mutations cause primary aldosteronism. They highlight the important role of chloride in aldosterone biosynthesis and identify ClC-2 as the foremost chloride conductor of resting glomerulosa cells. Primary aldosteronism is the most common and curable form of secondary arterial hypertension. We performed whole-exome sequencing in patients with early-onset primary aldosteronism and identified a de novo heterozygous c.71g>A/p.Gly24Asp mutation in the CLCN2 gene, encoding the voltage-gated ClC-2 chloride channel, in a patient diagnosed at 9 years of age. Patch-clamp analysis of glomerulosa cells of mouse adrenal gland slices showed hyperpolarization-activated Cl- currents that were abolished in Clcn2-/- mice. The p.Gly24Asp variant, located in a well-conserved 'inactivation domain', abolished the voltage- and time-dependent gating of ClC-2 and strongly increased Cl- conductance at resting potentials. Expression of ClC-2Asp24 in adrenocortical cells increased expression of aldosterone synthase and aldosterone production. Our data indicate that CLCN2 mutations cause primary aldosteronism. They highlight the important role of chloride in aldosterone biosynthesis and identify ClC-2 as the foremost chloride conductor of resting glomerulosa cells. Primary aldosteronism is the most common and curable form of secondary arterial hypertension. We performed whole-exome sequencing in patients with early-onset primary aldosteronism and identified a de novo heterozygous c.71G>A/p.Gly24Asp mutation in the CLCN2 gene, encoding the voltage-gated ClC-2 chloride channel , in a patient diagnosed at 9 years of age. Patch-clamp analysis of glomerulosa cells of mouse adrenal gland slices showed hyperpolarization-activated Cl currents that were abolished in Clcn2 mice. The p.Gly24Asp variant, located in a well-conserved 'inactivation domain' , abolished the voltage- and time-dependent gating of ClC-2 and strongly increased Cl conductance at resting potentials. Expression of ClC-2 in adrenocortical cells increased expression of aldosterone synthase and aldosterone production. Our data indicate that CLCN2 mutations cause primary aldosteronism. They highlight the important role of chloride in aldosterone biosynthesis and identify ClC-2 as the foremost chloride conductor of resting glomerulosa cells. |
Audience | Academic |
Author | Schwarzmayr, Thomas Göppner, Corinna Jeunemaitre, Xavier Orozco, Ian J. Jain, Vandana Boulkroun, Sheerazed Lefebvre, Hervé Daniil, Georgios Amar, Laurence Fernandes-Rosa, Fabio L. Strom, Tim M. Jentsch, Thomas J. El Zein, Rami Zennaro, Maria-Christina |
Author_xml | – sequence: 1 givenname: Fabio L. orcidid: 0000-0002-0162-0792 surname: Fernandes-Rosa fullname: Fernandes-Rosa, Fabio L. email: fabio.fernandes-rosa@inserm.fr organization: INSERM, UMRS 970, Paris Cardiovascular Research Center, Université Paris Descartes, Sorbonne Paris Cité, Assistance Publique–Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Génétique – sequence: 2 givenname: Georgios surname: Daniil fullname: Daniil, Georgios organization: INSERM, UMRS 970, Paris Cardiovascular Research Center, Université Paris Descartes, Sorbonne Paris Cité – sequence: 3 givenname: Ian J. surname: Orozco fullname: Orozco, Ian J. organization: Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Max Delbrück Centrum für Molekulare Medizin (MDC) – sequence: 4 givenname: Corinna surname: Göppner fullname: Göppner, Corinna organization: Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Max Delbrück Centrum für Molekulare Medizin (MDC) – sequence: 5 givenname: Rami surname: El Zein fullname: El Zein, Rami organization: INSERM, UMRS 970, Paris Cardiovascular Research Center, Université Paris Descartes, Sorbonne Paris Cité – sequence: 6 givenname: Vandana surname: Jain fullname: Jain, Vandana organization: Division of Pediatric Endocrinology, Department of Pediatrics, All India Institute of Medical Sciences – sequence: 7 givenname: Sheerazed surname: Boulkroun fullname: Boulkroun, Sheerazed organization: INSERM, UMRS 970, Paris Cardiovascular Research Center, Université Paris Descartes, Sorbonne Paris Cité – sequence: 8 givenname: Xavier orcidid: 0000-0001-5925-381X surname: Jeunemaitre fullname: Jeunemaitre, Xavier organization: INSERM, UMRS 970, Paris Cardiovascular Research Center, Université Paris Descartes, Sorbonne Paris Cité, Assistance Publique–Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Génétique – sequence: 9 givenname: Laurence surname: Amar fullname: Amar, Laurence organization: INSERM, UMRS 970, Paris Cardiovascular Research Center, Université Paris Descartes, Sorbonne Paris Cité, Assistance Publique–Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Unité Hypertension Artérielle – sequence: 10 givenname: Hervé surname: Lefebvre fullname: Lefebvre, Hervé organization: Normandie Université, UNIROUEN, INSERM, DC2N, Department of Endocrinology, Diabetes and Metabolic Diseases, University Hospital of Rouen – sequence: 11 givenname: Thomas surname: Schwarzmayr fullname: Schwarzmayr, Thomas organization: Institute of Human Genetics, Helmholtz Zentrum München – sequence: 12 givenname: Tim M. surname: Strom fullname: Strom, Tim M. organization: Institute of Human Genetics, Helmholtz Zentrum München, Institute of Human Genetics, Technische Universität München – sequence: 13 givenname: Thomas J. orcidid: 0000-0002-3509-2553 surname: Jentsch fullname: Jentsch, Thomas J. email: jentsch@fmp-berlin.de organization: Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Max Delbrück Centrum für Molekulare Medizin (MDC) – sequence: 14 givenname: Maria-Christina orcidid: 0000-0001-5449-9191 surname: Zennaro fullname: Zennaro, Maria-Christina email: maria-christina.zennaro@inserm.fr organization: INSERM, UMRS 970, Paris Cardiovascular Research Center, Université Paris Descartes, Sorbonne Paris Cité, Assistance Publique–Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Génétique |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29403012$$D View this record in MEDLINE/PubMed https://inserm.hal.science/inserm-02088868$$DView record in HAL |
BookMark | eNqNkk1v1DAQhiNURD_gB3BBkbiARIodJ7ZzXK0orbSiEl8XDpbjjHddJXZrJ4j-e2bJFtgKELIsj63nHY_H73F24IOHLHtKySklTL5OFa2lLAjFSWpWyAfZEa0rXlBB5QHGhNOiIowfZscpXRFCq4rIR9lh2eApoeVR9mWRr7XzRbCFnbwZXfD5MI36R-B8Pm4gX66W78rcbPoQXQcYaO-hz9fgcaOnBCm_jm7Q8TbXfRfSCDF4l4bH2UOr-wRPdutJ9unszcflebG6fHuxXKwKw2s2Fowaaa0pK1ZxgjXSpoNaGuhaDkIaI2wrKi5KwWUnjKlJW7fMVsxCw1oQhp1kr-a8G92rXSUqaKfOFyvlfII4KFISKSWXXyniL2b8OoabCdKoBpcM9L32EKakaNPU2EVRb9Hn99CrMEWPj1ElbYQQnIvfqLXuAS-0YYzabJOqRS1KTlgpCVKnf6BwdDA4gx9rHZ7vCV7uCZAZ4du4xo4ndfHh_f-zl5_32We7R03tAN3Pjt2ZAgExAyaGlCJYZdzsCKzY9YoStbWfmu2n0H5qaz8lUUnvKe-S_0tTzpqErF9D_NXjv4u-AyaL5rg |
CitedBy_id | crossref_primary_10_1530_EJE_17_0990 crossref_primary_10_1161_HYPERTENSIONAHA_119_12935 crossref_primary_10_1210_er_2018_00139 crossref_primary_10_1371_journal_pcbi_1007530 crossref_primary_10_1016_j_mce_2022_111613 crossref_primary_10_18632_aging_205028 crossref_primary_10_3390_biomedicines9080892 crossref_primary_10_1055_a_1139_2079 crossref_primary_10_1210_clinem_dgae142 crossref_primary_10_1210_jc_2018_01004 crossref_primary_10_1507_endocrj_EJ20_0478 crossref_primary_10_7554_eLife_90648 crossref_primary_10_1210_endrev_bnaa008 crossref_primary_10_1016_j_beem_2020_101386 crossref_primary_10_1038_s12276_019_0337_9 crossref_primary_10_1186_s12967_024_05769_5 crossref_primary_10_7554_eLife_90648_3 crossref_primary_10_1073_pnas_2009977117 crossref_primary_10_1210_clinem_dgz315 crossref_primary_10_1152_physrev_00047_2017 crossref_primary_10_1007_s40620_020_00700_9 crossref_primary_10_1007_s00467_021_05246_x crossref_primary_10_1016_j_beem_2020_101428 crossref_primary_10_3390_biomedicines9040409 crossref_primary_10_1161_CIRCULATIONAHA_118_033597 crossref_primary_10_1161_CIRCULATIONAHA_123_064028 crossref_primary_10_3389_fendo_2022_934326 crossref_primary_10_1016_j_beem_2020_101375 crossref_primary_10_1038_s41581_023_00753_6 crossref_primary_10_1111_joim_12831 crossref_primary_10_1161_HYPERTENSIONAHA_119_14177 crossref_primary_10_3390_cancers13184729 crossref_primary_10_3390_biomedicines9111708 crossref_primary_10_1161_HYPERTENSIONAHA_123_21446 crossref_primary_10_3390_cells9061332 crossref_primary_10_1016_j_kint_2022_12_021 crossref_primary_10_1016_j_redox_2025_103498 crossref_primary_10_3389_fendo_2021_728595 crossref_primary_10_1210_endocr_bqaa135 crossref_primary_10_3389_fendo_2022_931389 crossref_primary_10_3390_nu13030875 crossref_primary_10_1007_s11886_022_01735_z crossref_primary_10_1210_jendso_bvaa075 crossref_primary_10_1038_s41467_019_12113_9 crossref_primary_10_1038_s41556_022_00912_0 crossref_primary_10_1124_molpharm_122_000651 crossref_primary_10_1038_s41467_022_32896_8 crossref_primary_10_1007_s12031_020_01687_5 crossref_primary_10_1074_jbc_RA120_016031 crossref_primary_10_1152_ajpcell_00059_2021 crossref_primary_10_1073_pnas_2014876118 crossref_primary_10_1111_jch_14558 crossref_primary_10_1016_j_banm_2022_03_011 crossref_primary_10_1016_j_tem_2021_10_002 crossref_primary_10_3803_EnM_2023_1789 crossref_primary_10_1161_HYPERTENSIONAHA_124_23295 crossref_primary_10_1210_jendso_bvaa123 crossref_primary_10_1152_ajpcell_00334_2021 crossref_primary_10_3803_EnM_2019_34_4_355 crossref_primary_10_1097_HJH_0000000000002510 crossref_primary_10_1093_ajh_hpac079 crossref_primary_10_1038_s41440_023_01375_y crossref_primary_10_3389_fendo_2024_1286297 crossref_primary_10_1016_j_jfma_2023_08_021 crossref_primary_10_1097_CCO_0000000000000525 crossref_primary_10_3389_fendo_2021_683588 crossref_primary_10_3390_biomedicines10051041 crossref_primary_10_1016_j_soc_2022_10_007 crossref_primary_10_3389_fendo_2022_927669 crossref_primary_10_1016_j_mce_2021_111375 crossref_primary_10_3803_EnM_2021_101 crossref_primary_10_3389_fmolb_2023_1308754 crossref_primary_10_1210_jc_2019_00043 crossref_primary_10_1097_MED_0000000000000729 crossref_primary_10_1161_HYPERTENSIONAHA_118_11150 crossref_primary_10_1016_j_kint_2018_08_004 crossref_primary_10_1055_a_1120_8623 crossref_primary_10_20945_2359_3997000000507 crossref_primary_10_1186_s40246_020_00276_2 crossref_primary_10_7554_eLife_55701 crossref_primary_10_1016_j_coemr_2019_08_015 crossref_primary_10_1038_s41467_023_39218_6 crossref_primary_10_1016_j_ecl_2019_08_002 crossref_primary_10_1161_HYPERTENSIONAHA_118_11149 crossref_primary_10_18699_VJ18_443 crossref_primary_10_1161_HYPERTENSIONAHA_119_13156 crossref_primary_10_1038_s44319_025_00411_x crossref_primary_10_3390_ijms252111341 crossref_primary_10_1161_HYPERTENSIONAHA_121_16498 crossref_primary_10_3389_fendo_2021_644382 crossref_primary_10_1007_s00292_019_00682_x crossref_primary_10_1002_ccr3_8218 crossref_primary_10_1038_s41574_020_0382_4 crossref_primary_10_1007_s11906_019_0934_y crossref_primary_10_1210_jc_2018_00746 crossref_primary_10_1007_s00439_023_02531_7 crossref_primary_10_1161_HYPERTENSIONAHA_122_19557 crossref_primary_10_1055_a_2073_3202 crossref_primary_10_1161_HYPERTENSIONAHA_118_12070 crossref_primary_10_1007_s12672_019_00375_0 crossref_primary_10_1016_j_coemr_2019_08_006 crossref_primary_10_1038_s41598_020_58475_9 crossref_primary_10_1152_ajpgi_00087_2018 crossref_primary_10_1161_HYPERTENSIONAHA_119_13287 crossref_primary_10_1002_glia_23691 crossref_primary_10_1038_s41467_019_08841_7 crossref_primary_10_1161_HYPERTENSIONAHA_121_18761 crossref_primary_10_1146_annurev_physiol_030220_113038 crossref_primary_10_1210_clinem_dgae523 crossref_primary_10_21272_eumj_2021_9_1__46_53 crossref_primary_10_1016_j_molmed_2020_05_005 crossref_primary_10_1097_MNH_0000000000000702 crossref_primary_10_1093_ejendo_lvae041 crossref_primary_10_1016_j_tcm_2021_03_005 crossref_primary_10_1007_s00424_024_02950_z crossref_primary_10_1038_s41467_019_13033_4 crossref_primary_10_1016_S2213_8587_21_00210_2 crossref_primary_10_1021_acs_biochem_9b00051 crossref_primary_10_3390_ijms25147796 crossref_primary_10_1038_nrneph_2018_17 crossref_primary_10_3390_ijms19041124 crossref_primary_10_1038_s41591_022_02114_5 crossref_primary_10_1111_cen_13741 crossref_primary_10_3389_fendo_2021_632543 crossref_primary_10_1038_s41598_021_89986_8 |
Cites_doi | 10.1172/JCI61996 10.1055/s-0031-1298019 10.1161/HYPERTENSIONAHA.113.01060 10.1038/360759a0 10.1126/science.1198785 10.1038/355262a0 10.1038/35067500 10.1681/ASN.2011030245 10.1210/er.2017-00189 10.1523/JNEUROSCI.0338-07.2007 10.1124/jpet.108.145672 10.1113/jphysiol.2002.026096 10.1038/ng.2695 10.1073/pnas.95.14.8075 10.1038/ncomms4475 10.1146/annurev-med-042711-135929 10.1016/0039-128X(87)90097-3 10.1038/356057a0 10.1113/JP271896 10.1055/s-0031-1295438 10.1523/JNEUROSCI.6299-09.2010 10.1016/S0140-6736(16)31919-5 10.1016/S1474-4422(13)70053-X 10.1016/j.ebiom.2016.10.002 10.1016/j.jacc.2006.07.059 10.1111/j.1469-7793.1999.341ac.x 10.7554/eLife.06315 10.1210/jc.2015-4061 10.1161/HYPERTENSIONAHA.111.186478 10.1016/j.mce.2013.11.022 10.1212/WNL.0000000000000812 10.1038/415287a 10.1093/emboj/20.6.1289 10.1038/ng.2550 10.1038/ng.2716 10.1113/JP270043 10.1373/clinchem.2008.112797 10.1210/endo.141.2.7328 10.1126/science.1379744 10.1152/physrev.00030.2003 10.1159/000107528 10.1093/emboj/16.7.1582 |
ContentType | Journal Article |
Copyright | The Author(s) 2018 COPYRIGHT 2018 Nature Publishing Group Copyright Nature Publishing Group Mar 2018 Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: The Author(s) 2018 – notice: COPYRIGHT 2018 Nature Publishing Group – notice: Copyright Nature Publishing Group Mar 2018 – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | AAYXX CITATION NPM IOV ISR 3V. 7QL 7QP 7QR 7SS 7T7 7TK 7TM 7U9 7X7 7XB 88A 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7N M7P MBDVC P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U RC3 7X8 1XC VOOES |
DOI | 10.1038/s41588-018-0053-8 |
DatabaseName | CrossRef PubMed Opposing Viewpoints (Gale In Context) Science (Gale In Context) ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Entomology Abstracts (Full archive) Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) |
DatabaseTitle | CrossRef PubMed Research Library Prep ProQuest Central Student ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest SciTech Collection ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Research Library Prep PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Agriculture Biology |
EISSN | 1546-1718 |
EndPage | 361 |
ExternalDocumentID | oai_HAL_inserm_02088868v1 A572603280 29403012 10_1038_s41588_018_0053_8 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 123 29M 2FS 36B 39C 3O- 3V. 4.4 53G 5BI 5M7 5RE 5S5 70F 7X7 85S 88A 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AAEEF AAHBH AARCD AAYOK AAYZH AAZLF ABAWZ ABCQX ABDBF ABDPE ABEFU ABJNI ABLJU ABOCM ABTAH ABUWG ACBWK ACGFO ACGFS ACIWK ACMJI ACNCT ACPRK ACUHS ADBBV ADFRT AENEX AEUYN AFBBN AFFNX AFKRA AFRAH AFSHS AGAYW AGCDD AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH ARMCB ASPBG AVWKF AXYYD AZFZN AZQEC B0M BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU CS3 DB5 DU5 DWQXO EAD EAP EBC EBD EBS EE. EJD EMB EMK EMOBN EPL ESX EXGXG F5P FEDTE FQGFK FSGXE FYUFA GNUQQ GUQSH GX1 HCIFZ HMCUK HVGLF HZ~ IAO IH2 IHR INH INR IOV ISR ITC L7B LGEZI LK8 LOTEE M0L M1P M2O M7P MVM N9A NADUK NNMJJ NXXTH ODYON P2P PKN PQQKQ PROAC PSQYO Q2X RIG RNS RNT RNTTT RVV SHXYY SIXXV SJN SNYQT SOJ SV3 TAOOD TBHMF TDRGL TN5 TSG TUS UKHRP VQA X7M XJT XOL Y6R YHZ ZGI ZXP ZY4 ~8M ~KM AAYXX ACMFV AETEA AFANA ALPWD ATHPR CITATION PHGZM PHGZT NPM PMFND 7QL 7QP 7QR 7SS 7T7 7TK 7TM 7U9 7XB 8FD 8FK C1K FR3 H94 K9. M7N MBDVC P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U RC3 7X8 PUEGO 1XC ABFSG ACSTC AEZWR AFHIU AHWEU AIXLP NFIDA VOOES |
ID | FETCH-LOGICAL-c653t-31c8ffc24346000119de58cedb6e78cc7fb74672768d7cc50b5b3f43fe93be7c3 |
IEDL.DBID | 8C1 |
ISSN | 1061-4036 1546-1718 |
IngestDate | Fri Sep 12 12:50:16 EDT 2025 Fri Sep 05 13:43:18 EDT 2025 Fri Jul 25 09:11:48 EDT 2025 Tue Jun 17 21:45:14 EDT 2025 Tue Jun 10 20:45:46 EDT 2025 Fri Jun 27 05:08:29 EDT 2025 Fri Jun 27 03:49:40 EDT 2025 Wed Feb 19 02:35:53 EST 2025 Tue Jul 01 01:50:14 EDT 2025 Thu Apr 24 22:59:34 EDT 2025 Fri Feb 21 02:39:13 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c653t-31c8ffc24346000119de58cedb6e78cc7fb74672768d7cc50b5b3f43fe93be7c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Correspondence-1 content type line 23 |
ORCID | 0000-0002-0162-0792 0000-0001-5449-9191 0000-0001-5925-381X 0000-0002-3509-2553 0000-0003-3942-4276 |
OpenAccessLink | https://inserm.hal.science/inserm-02088868 |
PMID | 29403012 |
PQID | 2197776671 |
PQPubID | 33429 |
PageCount | 7 |
ParticipantIDs | hal_primary_oai_HAL_inserm_02088868v1 proquest_miscellaneous_1995154751 proquest_journals_2197776671 gale_infotracmisc_A572603280 gale_infotracacademiconefile_A572603280 gale_incontextgauss_ISR_A572603280 gale_incontextgauss_IOV_A572603280 pubmed_primary_29403012 crossref_citationtrail_10_1038_s41588_018_0053_8 crossref_primary_10_1038_s41588_018_0053_8 springer_journals_10_1038_s41588_018_0053_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-03-01 |
PublicationDateYYYYMMDD | 2018-03-01 |
PublicationDate_xml | – month: 03 year: 2018 text: 2018-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationTitle | Nature genetics |
PublicationTitleAbbrev | Nat Genet |
PublicationTitleAlternate | Nat Genet |
PublicationYear | 2018 |
Publisher | Nature Publishing Group US Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group US – name: Nature Publishing Group |
References | Rossi (CR10) 2006; 48 Di Bella (CR28) 2014; 83 Spät, Hunyady (CR30) 2004; 84 Hu, Rusin, Tan, Guagliardo, Barrett (CR40) 2012; 122 Daniil (CR15) 2016; 13 Gomez-Sanchez (CR43) 1987; 49 Hoegg-Beiler (CR26) 2014; 5 Depienne (CR27) 2013; 12 Thiemann, Gründer, Pusch, Jentsch (CR1) 1992; 356 Calhoun (CR6) 2013; 64 Boulkroun (CR29) 2012; 59 Jordt, Jentsch (CR2) 1997; 16 Koch (CR20) 1992; 257 Gründer, Thiemann, Pusch, Jentsch (CR3) 1992; 360 Choi (CR11) 2011; 331 (CR4) 2017; 389 Hubert (CR37) 2011; 22 Zennaro, Boulkroun, Fernandes-Rosa (CR7) 2017; 38 Beuschlein (CR16) 2013; 45 Lifton (CR17) 1992; 355 Pusch, Jordt, Stein, Jentsch (CR32) 1999; 515 Varela, Niemeyer, Cid, Sepúlveda (CR31) 2002; 544 Günther, Lüchow, Cluzeaud, Vandewalle, Jentsch (CR38) 1998; 95 Scholl (CR14) 2015; 4 Bösl (CR24) 2001; 20 Blanz (CR25) 2007; 27 Paul (CR35) 2007; 20 Scholl (CR13) 2013; 45 Hannemann, Wallaschofski (CR5) 2012; 44 Moss, Smart (CR18) 2001; 2 Savard, Amar, Plouin, Steichen (CR9) 2013; 62 Dutzler, Campbell, Cadene, Chait, MacKinnon (CR36) 2002; 415 Gomez-Sanchez (CR39) 2014; 383 Azizan (CR12) 2013; 45 Bustin (CR42) 2009; 55 Jentsch (CR23) 2015; 593 Funder (CR8) 2016; 101 Wang (CR41) 2012; 44 Rinke, Artmann, Stein (CR19) 2010; 30 Guo (CR21) 2014; 5 Chorvátová, Gendron, Bilodeau, Gallo-Payet, Payet (CR22) 2000; 141 Perez-Reyes, Van Deusen, Vitko (CR34) 2009; 328 Barrett (CR33) 2016; 594 JH Guo (53_CR21) 2014; 5 PQ Barrett (53_CR33) 2016; 594 D Varela (53_CR31) 2002; 544 A Hannemann (53_CR5) 2012; 44 GP Rossi (53_CR10) 2006; 48 M Choi (53_CR11) 2011; 331 SJ Moss (53_CR18) 2001; 2 R Dutzler (53_CR36) 2002; 415 J Blanz (53_CR25) 2007; 27 SA Bustin (53_CR42) 2009; 55 CE Gomez-Sanchez (53_CR43) 1987; 49 JW Funder (53_CR8) 2016; 101 D Bella Di (53_CR28) 2014; 83 F Beuschlein (53_CR16) 2013; 45 MC Zennaro (53_CR7) 2017; 38 MC Koch (53_CR20) 1992; 257 UI Scholl (53_CR13) 2013; 45 A Chorvátová (53_CR22) 2000; 141 UI Scholl (53_CR14) 2015; 4 CE Gomez-Sanchez (53_CR39) 2014; 383 NCD Risk Factor Collaboration (NCD-RisC). (53_CR4) 2017; 389 DA Calhoun (53_CR6) 2013; 64 S Savard (53_CR9) 2013; 62 TJ Jentsch (53_CR23) 2015; 593 EL Hubert (53_CR37) 2011; 22 M Pusch (53_CR32) 1999; 515 T Wang (53_CR41) 2012; 44 J Paul (53_CR35) 2007; 20 A Spät (53_CR30) 2004; 84 RP Lifton (53_CR17) 1992; 355 MB Hoegg-Beiler (53_CR26) 2014; 5 S Boulkroun (53_CR29) 2012; 59 A Thiemann (53_CR1) 1992; 356 W Günther (53_CR38) 1998; 95 E Perez-Reyes (53_CR34) 2009; 328 SE Jordt (53_CR2) 1997; 16 I Rinke (53_CR19) 2010; 30 C Depienne (53_CR27) 2013; 12 S Gründer (53_CR3) 1992; 360 G Daniil (53_CR15) 2016; 13 EA Azizan (53_CR12) 2013; 45 C Hu (53_CR40) 2012; 122 MR Bösl (53_CR24) 2001; 20 |
References_xml | – volume: 122 start-page: 2046 year: 2012 end-page: 2053 ident: CR40 article-title: Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators publication-title: J. Clin. Invest doi: 10.1172/JCI61996 – volume: 44 start-page: 245 year: 2012 end-page: 250 ident: CR41 article-title: Comparison of aldosterone production among human adrenocortical cell lines publication-title: Horm. Metab. Res doi: 10.1055/s-0031-1298019 – volume: 62 start-page: 331 year: 2013 end-page: 336 ident: CR9 article-title: Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.113.01060 – volume: 360 start-page: 759 year: 1992 end-page: 762 ident: CR3 article-title: Regions involved in the opening of CIC-2 chloride channel by voltage and cell volume publication-title: Nature doi: 10.1038/360759a0 – volume: 331 start-page: 768 year: 2011 end-page: 772 ident: CR11 article-title: K channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension publication-title: Science doi: 10.1126/science.1198785 – volume: 355 start-page: 262 year: 1992 end-page: 265 ident: CR17 article-title: A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension publication-title: Nature doi: 10.1038/355262a0 – volume: 2 start-page: 240 year: 2001 end-page: 250 ident: CR18 article-title: Constructing inhibitory synapses publication-title: Nat. Rev. Neurosci. doi: 10.1038/35067500 – volume: 22 start-page: 1997 year: 2011 end-page: 2003 ident: CR37 article-title: Mineralocorticoid receptor mutations and a severe recessive pseudohypoaldosteronism type 1 publication-title: J. Am. Soc. Nephrol doi: 10.1681/ASN.2011030245 – volume: 5 year: 2014 ident: CR21 article-title: Glucose-induced electrical activities and insulin secretion in pancreatic islet β-cells are modulated by CFTR publication-title: Nat. Commun. – volume: 38 start-page: 516 year: 2017 end-page: 537 ident: CR7 article-title: Genetic causes of functional adrenocortical adenomas publication-title: Endocr. Rev. doi: 10.1210/er.2017-00189 – volume: 27 start-page: 6581 year: 2007 end-page: 6589 ident: CR25 article-title: Leukoencephalopathy upon disruption of the chloride channel ClC-2 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0338-07.2007 – volume: 328 start-page: 621 year: 2009 end-page: 627 ident: CR34 article-title: Molecular pharmacology of human Ca 3.2 T-type Ca channels: block by antihypertensives, antiarrhythmics, and their analogs publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.108.145672 – volume: 544 start-page: 363 year: 2002 end-page: 372 ident: CR31 article-title: Effect of an N-terminus deletion on voltage-dependent gating of the ClC-2 chloride channel publication-title: J. Physiol. doi: 10.1113/jphysiol.2002.026096 – volume: 45 start-page: 1050 year: 2013 end-page: 1054 ident: CR13 article-title: Somatic and germline calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism publication-title: Nat. Genet. doi: 10.1038/ng.2695 – volume: 95 start-page: 8075 year: 1998 end-page: 8080 ident: CR38 article-title: ClC-5, the chloride channel mutated in Dent’s disease, colocalizes with the proton pump in endocytotically active kidney cells publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.95.14.8075 – volume: 5 year: 2014 ident: CR26 article-title: Disrupting MLC1 and GlialCAM and ClC-2 interactions in leukodystrophy entails glial chloride channel dysfunction publication-title: Nat. Commun. doi: 10.1038/ncomms4475 – volume: 64 start-page: 233 year: 2013 end-page: 247 ident: CR6 article-title: Hyperaldosteronism as a common cause of resistant hypertension publication-title: Annu. Rev. Med. doi: 10.1146/annurev-med-042711-135929 – volume: 49 start-page: 581 year: 1987 end-page: 587 ident: CR43 article-title: The production of monoclonal antibodies against aldosterone publication-title: Steroids doi: 10.1016/0039-128X(87)90097-3 – volume: 356 start-page: 57 year: 1992 end-page: 60 ident: CR1 article-title: A chloride channel widely expressed in epithelial and non-epithelial cells publication-title: Nature doi: 10.1038/356057a0 – volume: 594 start-page: 5851 year: 2016 end-page: 5860 ident: CR33 article-title: Role of voltage-gated calcium channels in the regulation of aldosterone production from zona glomerulosa cells of the adrenal cortex publication-title: J. Physiol. doi: 10.1113/JP271896 – volume: 44 start-page: 157 year: 2012 end-page: 162 ident: CR5 article-title: Prevalence of primary aldosteronism in patient’s cohorts and in population-based studies—a review of the current literature publication-title: Horm. Metab. Res. doi: 10.1055/s-0031-1295438 – volume: 30 start-page: 4776 year: 2010 end-page: 4786 ident: CR19 article-title: ClC-2 voltage-gated channels constitute part of the background conductance and assist chloride extrusion publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.6299-09.2010 – volume: 389 start-page: 37 year: 2017 end-page: 55 ident: CR4 article-title: Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants publication-title: Lancet doi: 10.1016/S0140-6736(16)31919-5 – volume: 12 start-page: 659 year: 2013 end-page: 668 ident: CR27 article-title: Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(13)70053-X – volume: 13 start-page: 225 year: 2016 end-page: 236 ident: CR15 article-title: mutations are associated with different forms of primary aldosteronism publication-title: EBioMedicine doi: 10.1016/j.ebiom.2016.10.002 – volume: 48 start-page: 2293 year: 2006 end-page: 2300 ident: CR10 article-title: A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2006.07.059 – volume: 515 start-page: 341 year: 1999 end-page: 353 ident: CR32 article-title: Chloride dependence of hyperpolarization-activated chloride channel gates publication-title: J. Physiol. doi: 10.1111/j.1469-7793.1999.341ac.x – volume: 4 year: 2015 ident: CR14 article-title: Recurrent gain of function mutation in calcium channel causes early-onset hypertension with primary aldosteronism publication-title: eLife doi: 10.7554/eLife.06315 – volume: 101 start-page: 1889 year: 2016 end-page: 1916 ident: CR8 article-title: The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2015-4061 – volume: 59 start-page: 592 year: 2012 end-page: 598 ident: CR29 article-title: Prevalence, clinical, and molecular correlates of mutations in primary aldosteronism publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.111.186478 – volume: 383 start-page: 111 year: 2014 end-page: 117 ident: CR39 article-title: Development of monoclonal antibodies against human CYP11B1 and CYP11B2 publication-title: Mol. Cell. Endocrinol doi: 10.1016/j.mce.2013.11.022 – volume: 83 start-page: 1217 year: 2014 end-page: 1218 ident: CR28 article-title: Subclinical leukodystrophy and infertility in a man with a novel homozygous mutation publication-title: Neurology doi: 10.1212/WNL.0000000000000812 – volume: 415 start-page: 287 year: 2002 end-page: 294 ident: CR36 article-title: X-ray structure of a ClC chloride channel at 3.0 Å reveals the molecular basis of anion selectivity publication-title: Nature doi: 10.1038/415287a – volume: 20 start-page: 1289 year: 2001 end-page: 1299 ident: CR24 article-title: Male germ cells and photoreceptors, both dependent on close cell–cell interactions, degenerate upon ClC-2 Cl channel disruption publication-title: EMBO J. doi: 10.1093/emboj/20.6.1289 – volume: 45 start-page: 440 year: 2013 end-page: 444 ident: CR16 article-title: Somatic mutations in and lead to aldosterone-producing adenomas and secondary hypertension publication-title: Nat. Genet. doi: 10.1038/ng.2550 – volume: 45 start-page: 1055 year: 2013 end-page: 1060 ident: CR12 article-title: Somatic mutations in and underlie a common subtype of adrenal hypertension publication-title: Nat. Genet. doi: 10.1038/ng.2716 – volume: 593 start-page: 4091 year: 2015 end-page: 4109 ident: CR23 article-title: Discovery of CLC transport proteins: cloning, structure, function and pathophysiology publication-title: J. Physiol. doi: 10.1113/JP270043 – volume: 55 start-page: 611 year: 2009 end-page: 622 ident: CR42 article-title: The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments publication-title: Clin. Chem doi: 10.1373/clinchem.2008.112797 – volume: 141 start-page: 684 year: 2000 end-page: 692 ident: CR22 article-title: A Ras-dependent chloride current activated by adrenocorticotropin in rat adrenal zona glomerulosa cells publication-title: Endocrinology doi: 10.1210/endo.141.2.7328 – volume: 257 start-page: 797 year: 1992 end-page: 800 ident: CR20 article-title: The skeletal muscle chloride channel in dominant and recessive human myotonia publication-title: Science doi: 10.1126/science.1379744 – volume: 84 start-page: 489 year: 2004 end-page: 539 ident: CR30 article-title: Control of aldosterone secretion: a model for convergence in cellular signaling pathways publication-title: Physiol. Rev. doi: 10.1152/physrev.00030.2003 – volume: 20 start-page: 441 year: 2007 end-page: 454 ident: CR35 article-title: Alterations in the cytoplasmic domain of CLCN2 result in altered gating kinetics publication-title: Cell. Physiol. Biochem. doi: 10.1159/000107528 – volume: 16 start-page: 1582 year: 1997 end-page: 1592 ident: CR2 article-title: Molecular dissection of gating in the ClC-2 chloride channel publication-title: EMBO J. doi: 10.1093/emboj/16.7.1582 – volume: 5 year: 2014 ident: 53_CR21 publication-title: Nat. Commun. – volume: 16 start-page: 1582 year: 1997 ident: 53_CR2 publication-title: EMBO J. doi: 10.1093/emboj/16.7.1582 – volume: 360 start-page: 759 year: 1992 ident: 53_CR3 publication-title: Nature doi: 10.1038/360759a0 – volume: 122 start-page: 2046 year: 2012 ident: 53_CR40 publication-title: J. Clin. Invest doi: 10.1172/JCI61996 – volume: 5 year: 2014 ident: 53_CR26 publication-title: Nat. Commun. doi: 10.1038/ncomms4475 – volume: 83 start-page: 1217 year: 2014 ident: 53_CR28 publication-title: Neurology doi: 10.1212/WNL.0000000000000812 – volume: 62 start-page: 331 year: 2013 ident: 53_CR9 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.113.01060 – volume: 20 start-page: 441 year: 2007 ident: 53_CR35 publication-title: Cell. Physiol. Biochem. doi: 10.1159/000107528 – volume: 331 start-page: 768 year: 2011 ident: 53_CR11 publication-title: Science doi: 10.1126/science.1198785 – volume: 84 start-page: 489 year: 2004 ident: 53_CR30 publication-title: Physiol. Rev. doi: 10.1152/physrev.00030.2003 – volume: 22 start-page: 1997 year: 2011 ident: 53_CR37 publication-title: J. Am. Soc. Nephrol doi: 10.1681/ASN.2011030245 – volume: 594 start-page: 5851 year: 2016 ident: 53_CR33 publication-title: J. Physiol. doi: 10.1113/JP271896 – volume: 59 start-page: 592 year: 2012 ident: 53_CR29 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.111.186478 – volume: 2 start-page: 240 year: 2001 ident: 53_CR18 publication-title: Nat. Rev. Neurosci. doi: 10.1038/35067500 – volume: 44 start-page: 157 year: 2012 ident: 53_CR5 publication-title: Horm. Metab. Res. doi: 10.1055/s-0031-1295438 – volume: 355 start-page: 262 year: 1992 ident: 53_CR17 publication-title: Nature doi: 10.1038/355262a0 – volume: 38 start-page: 516 year: 2017 ident: 53_CR7 publication-title: Endocr. Rev. doi: 10.1210/er.2017-00189 – volume: 257 start-page: 797 year: 1992 ident: 53_CR20 publication-title: Science doi: 10.1126/science.1379744 – volume: 141 start-page: 684 year: 2000 ident: 53_CR22 publication-title: Endocrinology doi: 10.1210/endo.141.2.7328 – volume: 45 start-page: 1050 year: 2013 ident: 53_CR13 publication-title: Nat. Genet. doi: 10.1038/ng.2695 – volume: 48 start-page: 2293 year: 2006 ident: 53_CR10 publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2006.07.059 – volume: 356 start-page: 57 year: 1992 ident: 53_CR1 publication-title: Nature doi: 10.1038/356057a0 – volume: 64 start-page: 233 year: 2013 ident: 53_CR6 publication-title: Annu. Rev. Med. doi: 10.1146/annurev-med-042711-135929 – volume: 30 start-page: 4776 year: 2010 ident: 53_CR19 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.6299-09.2010 – volume: 593 start-page: 4091 year: 2015 ident: 53_CR23 publication-title: J. Physiol. doi: 10.1113/JP270043 – volume: 415 start-page: 287 year: 2002 ident: 53_CR36 publication-title: Nature doi: 10.1038/415287a – volume: 55 start-page: 611 year: 2009 ident: 53_CR42 publication-title: Clin. Chem doi: 10.1373/clinchem.2008.112797 – volume: 4 year: 2015 ident: 53_CR14 publication-title: eLife doi: 10.7554/eLife.06315 – volume: 27 start-page: 6581 year: 2007 ident: 53_CR25 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0338-07.2007 – volume: 544 start-page: 363 year: 2002 ident: 53_CR31 publication-title: J. Physiol. doi: 10.1113/jphysiol.2002.026096 – volume: 383 start-page: 111 year: 2014 ident: 53_CR39 publication-title: Mol. Cell. Endocrinol doi: 10.1016/j.mce.2013.11.022 – volume: 389 start-page: 37 year: 2017 ident: 53_CR4 publication-title: Lancet doi: 10.1016/S0140-6736(16)31919-5 – volume: 44 start-page: 245 year: 2012 ident: 53_CR41 publication-title: Horm. Metab. Res doi: 10.1055/s-0031-1298019 – volume: 328 start-page: 621 year: 2009 ident: 53_CR34 publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.108.145672 – volume: 45 start-page: 440 year: 2013 ident: 53_CR16 publication-title: Nat. Genet. doi: 10.1038/ng.2550 – volume: 515 start-page: 341 year: 1999 ident: 53_CR32 publication-title: J. Physiol. doi: 10.1111/j.1469-7793.1999.341ac.x – volume: 95 start-page: 8075 year: 1998 ident: 53_CR38 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.95.14.8075 – volume: 49 start-page: 581 year: 1987 ident: 53_CR43 publication-title: Steroids doi: 10.1016/0039-128X(87)90097-3 – volume: 45 start-page: 1055 year: 2013 ident: 53_CR12 publication-title: Nat. Genet. doi: 10.1038/ng.2716 – volume: 20 start-page: 1289 year: 2001 ident: 53_CR24 publication-title: EMBO J. doi: 10.1093/emboj/20.6.1289 – volume: 101 start-page: 1889 year: 2016 ident: 53_CR8 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2015-4061 – volume: 13 start-page: 225 year: 2016 ident: 53_CR15 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2016.10.002 – volume: 12 start-page: 659 year: 2013 ident: 53_CR27 publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(13)70053-X |
SSID | ssj0014408 |
Score | 2.599537 |
Snippet | Primary aldosteronism is the most common and curable form of secondary arterial hypertension. We performed whole-exome sequencing in patients with early-onset... |
SourceID | hal proquest gale pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 355 |
SubjectTerms | 13/109 45/23 45/90 64/60 692/699/2743/1279 692/699/75/243 Adrenal glands Age Agriculture Aldosterone Aldosterone synthase Animal Genetics and Genomics Biomedical and Life Sciences Biomedicine Biosynthesis Cancer Research Cardiology and cardiovascular system Cardiovascular disease Causes of Channel gating Chloride Chloride channels Chloride conductance Chloride currents Chloride ions Conductors Deactivation Electric potential Endocrine disorders Endocrinology and metabolism Gene Function Gene mutation Genes Genetic aspects Genetics Glucocorticoids Homeostasis Human Genetics Human health and pathology Hyperaldosteronism Hyperpolarization Hypertension Inactivation Ion channels Letter Life Sciences Mutation Patients Resistance Steroids (Organic compounds) Time dependence Tumors |
Title | A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism |
URI | https://link.springer.com/article/10.1038/s41588-018-0053-8 https://www.ncbi.nlm.nih.gov/pubmed/29403012 https://www.proquest.com/docview/2197776671 https://www.proquest.com/docview/1995154751 https://inserm.hal.science/inserm-02088868 |
Volume | 50 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfoJiReEN8rjMogEBIoWhIntvOESrWpoFHQYKgSD1bs2BtSmwzSIvHfc5c4maJpe-hDlUvinM_nO9_Hj5BXAuFsCxcG2mgXJCaNgjySYSCzwsa5DjPXoDV8XvD5afJpmS79gVvt0yo7ndgo6qIyeEZ-ACtLCMG5iN5f_A4QNQqjqx5CY0R2sQYUnS8561M8MG7ZlsJx9JMY76KaTB7UsHFJTOOCH8hhIAf7ktfOo3NMjrxqeV6Jmjab0dE9ctdbkXTaTvt9csuWD8jtFlfy30Pyc0rPwOMPKhfgvoW8p-ttG3Snv0oKRh-dHc8WMTXnmIFXWIoFwKVdUZAn-JNva1vTi7YTBc1XBZaCYBfdev2InB4dfp_NA4-iEBiesg0oWSOdM3HCEt5YgDALqTS20NwKaYxwGiFHYvA7CmFMGupUM5cwZzOmrTDsMdkpq9LuESrwwNRJF1ltElbonBfgwknuMinBkInHJOx4qIxvMY5IFyvVhLqZVC3bFbBdIduVHJO3_S3-q24ifokTo7BvRYmJMWfAjlp9_PJDTVMBnhmLZXgd0beTAdEbT-QqGKHJfTECfCf2wxpQ7g8oYfWZweXXICT90LFZ93x6DNSgQNYKEVCl5PJvBI_pxEh5LVGrS5kekxf9ZXwDZr6VttrWCkvowcwVKdA8acWvf1ucJejRAt_fdfJ4-fBrufj05qE8I3fiZllgnt0-2dn82drnYHht9ISMxFJMmjU2IbsfDhdfT_4DJQkmyg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw1NqGELwg7hQGGMSEBIqWxIntPCBUFaaWdUWCbarEg4kde5vUJoO0oP0U38g5uU3VtL3toQ9VThzn-FxzboS8ETjONnO-p412XmTiwEsD6XsyyWyYaj9x1bSGvQkfHkRfpvF0jfxra2EwrbKViZWgzgqD38i3gbOEEJyL4OPpLw-nRmF0tR2hUZPFrj37Cy5b-WH0Cc53Kwx3Pu8Phl4zVcAzPGYLEDpGOmfCiEW8sohgV7E0NtPcCmmMcBpHcIRgh2fCmNjXsWYuYs4mTFthGKy7Tm5EGGIE_hHTzsHDOGldesfRL2O8jaIyuV2CopSYNgY_oHtPrujBRhusH2My5kVL90KUtlJ-O3fJncZqpf2azO6RNZvfJzfrOZZnD8iPPj1KT3KvcB7qSTxrOl_WQX56klMwMulgPJiE1Bxjxl9mKRYc53ZGgX7hT7osbUlP684XNJ1lWHqCXXvL-UNycC34fUQ28iK3TwgV-IHWSRdYbSKW6ZRn4DJK7hIpwXAKe8RvcahM09IcJ2vMVBVaZ1LVaFeAdoVoV7JH3nW3NG91FfBrPBiFfTJyTMQ5AnSUavT1UPVjAZ4gC6V_GdD3bytAbxsgV8AOTdoUP8B7Yv-tFcjNFUjgdrNyeQuIpNs6Ngcf9scADQJrrnDiqpRc_glgmZaMVCOVSnXOQz3yqruMT8BMu9wWy1JhyT6Y1SIGmMc1-XVPC5MIPWjA-_uWHs8XvxSLT6_eyktya7i_N1bj0WT3GbkdViyCOX6bZGPxe2mfg9G30C8qTqPk53Wz9n9Os2IH |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw1NpFIF4QdwoDDGJCAkVN48R2HyZUulUtK2UaG5rEg4kde5vUpoO0oP0iX8U5idOpmra3PeQhyonjnJxrzo2QtwLH2WYuDLTRLohN0grSlgwD2c5slOqw7cppDV9GvH8Yfz5KjlbIv7oWBtMqa5lYCupsavAfeRM4SwjBuWg1nU-L2NvufTz7FeAEKYy01uM0Uj9mIdsq2435Io9de_4X3Llia7AN334zino7B91-4CcOBIYnbAYCyUjnTBSzmJfWEuw4kcZmmlshjRFO43iOCGz0TBiThDrRzMXM2TbTVhgG666SdQFaHxzB9U87o739RUwDZzuXsVeOXhvjdYyVyWYBalRiUhkcwBWBXNKSXlesnmCq5mU7-FIMt1SNvXvkrrdpaaciwvtkxeYPyK1qyuX5Q_KjQ4_T0zyYugC1KFICncyrFAB6mlMwQWl32B1F1JxgPmBmKZYj53ZMgbrhJJ0XtqBnVV8Mmo4zLEzBnr7F5BE5vBEMPyZr-TS3TwkV-PvWSdey2sQs0ynPwKGU3LWlBLMqapCwxqEyvuE5zt0YqzLwzqSq0K4A7QrRrmSDvF_c4t_qOuA3-GEUdtHIkR6PAR2FGnz9rjqJAD-RRTK8Cujb_hLQOw_kprBDk_rSCHhP7M61BLmxBAmywCxd3gQiWWwdW4f3O0OABnE2UTiPVUou_7RgmZqMlJdZhbrgsAZ5vbiMT8A8vNxO54XCgn4wukUCME8q8ls8LWrH6F8D3j_U9Hix-JVYfHb9Vl6R28DmajgY7T4nd6KSQzABcIOszX7P7QuwCGf6pWc1Sn7eNHf_B6KabOI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+gain-of-function+mutation+in+the+CLCN2+chloride+channel+gene+causes+primary+aldosteronism&rft.jtitle=Nature+genetics&rft.au=Fernandes-Rosa%2C+Fabio+L.&rft.au=Daniil%2C+Georgios&rft.au=Orozco%2C+Ian+J.&rft.au=G%C3%B6ppner%2C+Corinna&rft.date=2018-03-01&rft.issn=1061-4036&rft.eissn=1546-1718&rft.volume=50&rft.issue=3&rft.spage=355&rft.epage=361&rft_id=info:doi/10.1038%2Fs41588-018-0053-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41588_018_0053_8 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1061-4036&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1061-4036&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1061-4036&client=summon |